Hoth Book Value per Share vs Net Income Analysis
HOTH Stock | USD 1.17 0.02 1.68% |
Hoth Therapeutics financial indicator trend analysis is much more than just examining Hoth Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hoth Therapeutics is a good investment. Please check the relationship between Hoth Therapeutics Book Value Per Share and its Net Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
Book Value Per Share vs Net Income
Book Value per Share vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hoth Therapeutics Book Value per Share account and Net Income. At this time, the significance of the direction appears to have pay attention.
The correlation between Hoth Therapeutics' Book Value per Share and Net Income is -0.86. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Net Income in the same time period over historical financial statements of Hoth Therapeutics, assuming nothing else is changed. The correlation between historical values of Hoth Therapeutics' Book Value per Share and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of Hoth Therapeutics are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Book Value per Share i.e., Hoth Therapeutics' Book Value per Share and Net Income go up and down completely randomly.
Correlation Coefficient | -0.86 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Hoth Therapeutics financial statement analysis. It represents the amount of money remaining after all of Hoth Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from Hoth Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' Enterprise Value Over EBITDA is increasing as compared to previous years. The Hoth Therapeutics' current Enterprise Value Multiple is estimated to increase to 0.59, while Selling General Administrative is projected to decrease to 4,002.
Hoth Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.8M | 5.2M | 11.0M | 6.8M | 9.5M | 5.8M | |
Other Current Liab | 36.2K | 182.7K | 506.8K | 692.7K | 614.2K | 352.1K | |
Total Current Liabilities | 440.1K | 312.1K | 867.8K | 1.4M | 678.7K | 641.9K | |
Total Stockholder Equity | 2.4M | 4.6M | 9.9M | 5.1M | 8.8M | 5.1M | |
Net Tangible Assets | 154.7K | 2.4M | 4.6M | 9.9M | 11.4M | 11.9M | |
Net Debt | (1.7M) | (2.6M) | (8.5M) | (6.4M) | (9.2M) | (8.8M) | |
Retained Earnings | (12.2M) | (19.4M) | (33.7M) | (45.1M) | (52.9M) | (50.3M) | |
Accounts Payable | 403.9K | 129.5K | 361.0K | 695.0K | 35.6K | 33.8K | |
Cash | 1.7M | 2.6M | 8.5M | 6.4M | 9.3M | 4.7M | |
Non Current Assets Total | 201.0K | 460K | 410K | 33K | 92.6K | 87.9K | |
Non Currrent Assets Other | 200K | 50K | 0.0 | 33K | (1.0) | (0.95) | |
Cash And Short Term Investments | 2.5M | 4.7M | 10.4M | 6.6M | 9.3M | 5.5M | |
Common Stock Shares Outstanding | 366.6K | 494.5K | 893.2K | 1.2M | 3.4M | 1.8M | |
Liabilities And Stockholders Equity | 2.8M | 5.2M | 11.0M | 6.8M | 9.5M | 5.8M | |
Non Current Liabilities Total | 403.9K | 285K | 235K | 250K | 26.3K | 25.0K | |
Other Stockholder Equity | 14.6M | 24.1M | 43.6M | 50.2M | 61.7M | 31.8M | |
Total Liab | 440.1K | 597.1K | 1.1M | 1.6M | 705.0K | 767.0K | |
Net Invested Capital | 2.4M | 4.6M | 9.9M | 5.1M | 8.8M | 5.1M | |
Total Current Assets | 2.6M | 4.8M | 10.6M | 6.7M | 9.4M | 5.6M | |
Net Working Capital | 2.2M | 4.5M | 9.7M | 5.3M | 8.7M | 5.0M | |
Common Stock | 1.0K | 1.3K | 2.4K | 130.0 | 435.0 | 413.25 | |
Other Current Assets | 140.6K | 89.8K | 94.0M | 88.5K | 135.4K | 128.6K | |
Capital Stock | 1.0K | 1.3K | 2.4K | 130.0 | 435.0 | 818.0 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hoth Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hoth Therapeutics' short interest history, or implied volatility extrapolated from Hoth Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.